In an ongoing effort to provide the needed COVID-19 care and treatment for the community it serves, Lincoln Medical Center (LMC) is offering Monoclonal Antibody Infusions to eligible COVID-positive patients.
Monoclonal antibodies are man-made proteins that mimic the antibodies naturally made by the body’s immune system. According to fda.gov, “Monoclonal antibodies for COVID-19 may block the virus that causes COVID-19 from attaching to human cells, making it more difficult for the virus to reproduce and cause harm. Monoclonal antibodies may also neutralize a virus.”
This treatment has received emergency use authorization by the FDA for the treatment of non-hospitalized COVID-19 positive patients with mild to moderate symptoms.
Monoclonal Antibody infusions require a physician’s order and are most effective when given soon after the initial diagnosis. The treatment process includes an intravenous infusion which takes approximately 20 minutes. Patients may need to be monitored for a period of time after the infusion.
For more information, or to determine if you are eligible for a Monoclonal Antibody Infusion, please contact your primary care provider or visit the ‘Find A Doc’ page on our website at www.LincolnHealthSystem.com.